{"draw":1,"recordsFiltered":13775,"recordsTotal":13775,"data":[{"__attributes":{"id":"post-row-93957","class":"post-row post-type-post post-93957 publish"},"date":" 16 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708.png\" class=\"\" alt=\"FDA Advisory No.2024-1708 || Common Services Laboratory (CSL) Submission Holiday\" loading=\"lazy\" title=\"FDA Advisory No.2024-1708\" data-caption=\"FDA Advisory No.2024-1708 || Common Services Laboratory (CSL) Submission Holiday\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1708-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1708-common-services-laboratory-csl-submission-holiday\/\">FDA Advisory No.2024-1708 || Common Services Laboratory (CSL) Submission Holiday<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/general-advisories\/\" rel=\"category tag\">General Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93953","class":"post-row post-type-post post-93953 publish"},"date":" 16 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707.png\" class=\"\" alt=\"FDA Advisory No.2024-1707 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MANNY ESSENTIAL FACE AND BODY SOAP WITH MOISTURIZER&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1707\" data-caption=\"FDA Advisory No.2024-1707 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MANNY ESSENTIAL FACE AND BODY SOAP WITH MOISTURIZER&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1707-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1707-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-manny-essential-face-and-body-soap-with-moisturizer\/\">FDA Advisory No.2024-1707 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MANNY ESSENTIAL FACE AND BODY SOAP WITH MOISTURIZER&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93949","class":"post-row post-type-post post-93949 publish"},"date":" 16 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706.png\" class=\"\" alt=\"FDA Advisory No.2024-1706 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;SCOBAN MOUTHWASH (PEACH FLAVOR, MINT FLAVOR)&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1706\" data-caption=\"FDA Advisory No.2024-1706 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;SCOBAN MOUTHWASH (PEACH FLAVOR, MINT FLAVOR)&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1706-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1706-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-scoban-mouthwash-peach-flavor-mint-flavor\/\">FDA Advisory No.2024-1706 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;SCOBAN MOUTHWASH (PEACH FLAVOR, MINT FLAVOR)&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93945","class":"post-row post-type-post post-93945 publish"},"date":" 16 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1651-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cCURE SHE Cytotic Tablets Misoprostol 200 \u00b5g Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1651-A\" data-caption=\"FDA Advisory No.2024-1651-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cCURE SHE Cytotic Tablets Misoprostol 200 \u00b5g Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1651-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-cure-she-cytotic-tablets-misoprostol-200-%c2%b5g-tablet\/\">FDA Advisory No.2024-1651-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cCURE SHE Cytotic Tablets Misoprostol 200 \u00b5g Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93941","class":"post-row post-type-post post-93941 publish"},"date":" 16 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651.png\" class=\"\" alt=\"FDA Advisory No.2024-1651 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cCURE SHE Cytotic Tablets Misoprostol  200 \u00b5g Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1651\" data-caption=\"FDA Advisory No.2024-1651 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cCURE SHE Cytotic Tablets Misoprostol  200 \u00b5g Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1651-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1651-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-cure-she-cytotic-tablets-misoprostol-200-%c2%b5g-tablet\/\">FDA Advisory No.2024-1651 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cCURE SHE Cytotic Tablets Misoprostol  200 \u00b5g Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93935","class":"post-row post-type-post post-93935 publish"},"date":" 16 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1650-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot [Illegally diverted] \u201cRabies Vaccine, Human I.P. (Purified Chick Embryo Cell Culture Rabies Vaccine) [PCECVPM] (Vaxirab N) \u2265 2.5 IU Lyophilized Powder for Solution for Injection (IM\/ID) with Sterile Water for Injection IP (Batch No. RV40015, Expiry date: JAN.27; Diluent Batch No.: CH223004, Diluent Expiry Date: OCT. 2028; Syringe Batch No.: 3223843, Syringe Expiry Date: 2028-07)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1650-A\" data-caption=\"FDA Advisory No.2024-1650-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot [Illegally diverted] \u201cRabies Vaccine, Human I.P. (Purified Chick Embryo Cell Culture Rabies Vaccine) [PCECVPM] (Vaxirab N) \u2265 2.5 IU Lyophilized Powder for Solution for Injection (IM\/ID) with Sterile Water for Injection IP (Batch No. RV40015, Expiry date: JAN.27; Diluent Batch No.: CH223004, Diluent Expiry Date: OCT. 2028; Syringe Batch No.: 3223843, Syringe Expiry Date: 2028-07)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1650-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-illegally-diverted-rabies-vaccine-human-i-p-purified-chick-embryo-cell-culture\/\">FDA Advisory No.2024-1650-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot [Illegally diverted] \u201cRabies Vaccine, Human I.P. (Purified Chick Embryo Cell Culture Rabies Vaccine) [PCECVPM] (Vaxirab N) \u2265 2.5 IU Lyophilized Powder for Solution for Injection (IM\/ID) with Sterile Water for Injection IP (Batch No. RV40015, Expiry date: JAN.27; Diluent Batch No.: CH223004, Diluent Expiry Date: OCT. 2028; Syringe Batch No.: 3223843, Syringe Expiry Date: 2028-07)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93931","class":"post-row post-type-post post-93931 publish"},"date":" 16 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650.png\" class=\"\" alt=\"FDA Advisory No.2024-1650 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product [Illegally diverted] \u201cRabies Vaccine, Human I.P. (Purified Chick Embryo Cell Culture Rabies Vaccine) [PCECVPM] (Vaxirab N) \u2265 2.5 IU Lyophilized Powder for Solution for Injection (IM\/ID) with Sterile Water for Injection IP (Batch No. RV40015, Expiry date: JAN.27; Diluent Batch No.: CH223004, Diluent Expiry Date: OCT. 2028;  Syringe Batch No.: 3223843, Syringe Expiry Date: 2028-07)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1650\" data-caption=\"FDA Advisory No.2024-1650 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product [Illegally diverted] \u201cRabies Vaccine, Human I.P. (Purified Chick Embryo Cell Culture Rabies Vaccine) [PCECVPM] (Vaxirab N) \u2265 2.5 IU Lyophilized Powder for Solution for Injection (IM\/ID) with Sterile Water for Injection IP (Batch No. RV40015, Expiry date: JAN.27; Diluent Batch No.: CH223004, Diluent Expiry Date: OCT. 2028;  Syringe Batch No.: 3223843, Syringe Expiry Date: 2028-07)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1650-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1650-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-illegally-diverted-rabies-vaccine-human-i-p-purified-chick-embryo-cell-cu\/\">FDA Advisory No.2024-1650 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product [Illegally diverted] \u201cRabies Vaccine, Human I.P. (Purified Chick Embryo Cell Culture Rabies Vaccine) [PCECVPM] (Vaxirab N) \u2265 2.5 IU Lyophilized Powder for Solution for Injection (IM\/ID) with Sterile Water for Injection IP (Batch No. RV40015, Expiry date: JAN.27; Diluent Batch No.: CH223004, Diluent Expiry Date: OCT. 2028;  Syringe Batch No.: 3223843, Syringe Expiry Date: 2028-07)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93925","class":"post-row post-type-post post-93925 publish"},"date":" 16 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1649-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1649-A\" data-caption=\"FDA Advisory No.2024-1649-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1649-a-babala-sa-publiko-tungkol-sa-paggamit-ng-mga-sumusunod-na-beripikadong-pekeng-gamot-na\/\">FDA Advisory No.2024-1649-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93918","class":"post-row post-type-post post-93918 publish"},"date":" 16 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649.png\" class=\"\" alt=\"FDA Advisory No.2024-1649 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1649\" data-caption=\"FDA Advisory No.2024-1649 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1649-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1649-public-health-warning-against-the-purchase-and-use-of-the-following-verified-counterfeit-drug-products\/\">FDA Advisory No.2024-1649 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93887","class":"post-row post-type-post post-93887 publish"},"date":" 13 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660.png\" class=\"\" alt=\"FDA Advisory No.2024-1660 || Regulatory Updates on the Implementation of Food and Drug Administration (FDA) Circular No. 2020-025\" loading=\"lazy\" title=\"FDA Advisory No.2024-1660\" data-caption=\"FDA Advisory No.2024-1660 || Regulatory Updates on the Implementation of Food and Drug Administration (FDA) Circular No. 2020-025\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1660-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1660\/\">FDA Advisory No.2024-1660 || Regulatory Updates on the Implementation of Food and Drug Administration (FDA) Circular No. 2020-025<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93856","class":"post-row post-type-post post-93856 publish"},"date":" 11 December 2024","image":"","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1658-reminders-on-collectible-toys\/\">FDA Advisory No.2024-1658 || Reminders on Collectible Toys<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93829","class":"post-row post-type-post post-93829 publish"},"date":" 10 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655.png\" class=\"\" alt=\"FDA Advisory No.2024-1655 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;NUTRIVISAGE FACIAL FOAM ANTI-ACNE OIL BALANCING &amp; CALMING FORMULA&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1655\" data-caption=\"FDA Advisory No.2024-1655 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;NUTRIVISAGE FACIAL FOAM ANTI-ACNE OIL BALANCING &amp; CALMING FORMULA&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1655-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1655-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-nutrivisage-facial-foam-anti-acne-oil-balancing-calming-formula\/\">FDA Advisory No.2024-1655 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;NUTRIVISAGE FACIAL FOAM ANTI-ACNE OIL BALANCING &#038; CALMING FORMULA&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93825","class":"post-row post-type-post post-93825 publish"},"date":" 10 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654.png\" class=\"\" alt=\"FDA Advisory No.2024-1654 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;AVEENO BABY ECZEMA THERAPY MOISTURIZING CREAM&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1654\" data-caption=\"FDA Advisory No.2024-1654 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;AVEENO BABY ECZEMA THERAPY MOISTURIZING CREAM&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1654-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1654-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-aveeno-baby-eczema-therapy-moisturizing-cream\/\">FDA Advisory No.2024-1654 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;AVEENO BABY ECZEMA THERAPY MOISTURIZING CREAM&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93821","class":"post-row post-type-post post-93821 publish"},"date":" 10 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653.png\" class=\"\" alt=\"FDA Advisory No.2024-1653 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ANEEZA GOLD BEAUTY SOAP WITH AVOCADO OIL &amp; ALOE VERA EXTRACT&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1653\" data-caption=\"FDA Advisory No.2024-1653 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ANEEZA GOLD BEAUTY SOAP WITH AVOCADO OIL &amp; ALOE VERA EXTRACT&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1653-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1653-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-aneeza-gold-beauty-soap-with-avocado-oil-aloe-vera-extract\/\">FDA Advisory No.2024-1653 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;ANEEZA GOLD BEAUTY SOAP WITH AVOCADO OIL &#038; ALOE VERA EXTRACT&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93817","class":"post-row post-type-post post-93817 publish"},"date":" 10 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652.png\" class=\"\" alt=\"FDA Advisory No.2024-1652 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;TOP ARMPIT WHITENING DEO CREAM&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1652\" data-caption=\"FDA Advisory No.2024-1652 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;TOP ARMPIT WHITENING DEO CREAM&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1652-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1652-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-top-armpit-whitening-deo-cream\/\">FDA Advisory No.2024-1652 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;TOP ARMPIT WHITENING DEO CREAM&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93803","class":"post-row post-type-post post-93803 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644.png\" class=\"\" alt=\"FDA Advisory No.2024-1644 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MEIDUODUO SNAIL WHITE 99% MOISTURIZING ALOE GEL&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1644\" data-caption=\"FDA Advisory No.2024-1644 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MEIDUODUO SNAIL WHITE 99% MOISTURIZING ALOE GEL&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1644-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1644-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-meiduoduo-snail-white-99-moisturizing-aloe-gel\/\">FDA Advisory No.2024-1644 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MEIDUODUO SNAIL WHITE 99% MOISTURIZING ALOE GEL&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93799","class":"post-row post-type-post post-93799 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643.png\" class=\"\" alt=\"FDA Advisory No.2024-1643 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;COTTON CLEAN EMOLLIENTS WIPES&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1643\" data-caption=\"FDA Advisory No.2024-1643 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;COTTON CLEAN EMOLLIENTS WIPES&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1643-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1643-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-cotton-clean-emollients-wipes\/\">FDA Advisory No.2024-1643 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;COTTON CLEAN EMOLLIENTS WIPES&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93795","class":"post-row post-type-post post-93795 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642.png\" class=\"\" alt=\"FDA Advisory No.2024-1642 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;LBLS SAKURA NIACINAMIDE BODY LOTION&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1642\" data-caption=\"FDA Advisory No.2024-1642 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;LBLS SAKURA NIACINAMIDE BODY LOTION&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1642-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1642-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-lbls-sakura-niacinamide-body-lotion\/\">FDA Advisory No.2024-1642 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;LBLS SAKURA NIACINAMIDE BODY LOTION&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93791","class":"post-row post-type-post post-93791 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641.png\" class=\"\" alt=\"FDA Advisory No.2024-1641 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;SOFT SUB PROFESSIONAL PROTECTION TOUCH COLOR 006 DARK BLONDE&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1641\" data-caption=\"FDA Advisory No.2024-1641 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;SOFT SUB PROFESSIONAL PROTECTION TOUCH COLOR 006 DARK BLONDE&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1641-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1641-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-soft-sub-professional-protection-touch-color-006-dark-blonde\/\">FDA Advisory No.2024-1641 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;SOFT SUB PROFESSIONAL PROTECTION TOUCH COLOR 006 DARK BLONDE&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93786","class":"post-row post-type-post post-93786 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640.png\" class=\"\" alt=\"FDA Advisory No.2024-1640 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;DM BEAUTY SECRET WHITENING SKIN PERFECT&quot;\" loading=\"lazy\" title=\"1640\" data-caption=\"FDA Advisory No.2024-1640 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;DM BEAUTY SECRET WHITENING SKIN PERFECT&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1640-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1640-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-dm-beauty-secret-whitening-skin-perfect\/\">FDA Advisory No.2024-1640 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;DM BEAUTY SECRET WHITENING SKIN PERFECT&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93782","class":"post-row post-type-post post-93782 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639.png\" class=\"\" alt=\"FDA Advisory No.2024-1639 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;88 WHITENING NIGHT CREAM&quot;\" loading=\"lazy\" title=\"1639\" data-caption=\"FDA Advisory No.2024-1639 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;88 WHITENING NIGHT CREAM&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/1639-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1639-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-88-whitening-night-cream\/\">FDA Advisory No.2024-1639 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;88 WHITENING NIGHT CREAM&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93773","class":"post-row post-type-post post-93773 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638.png\" class=\"\" alt=\"FDA Advisory No.2024-1638 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;BLACKSWAN SAKURA NIACINAMIDE BODY LOTION WHITENING&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1638\" data-caption=\"FDA Advisory No.2024-1638 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;BLACKSWAN SAKURA NIACINAMIDE BODY LOTION WHITENING&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1638-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1638-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-blackswan-sakura-niacinamide-body-lotion-whitening\/\">FDA Advisory No.2024-1638 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;BLACKSWAN SAKURA NIACINAMIDE BODY LOTION WHITENING&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93771","class":"post-row post-type-post post-93771 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645.png\" class=\"\" alt=\"FDA Advisory No.2024-1645 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;LA BELLA VIVA EAU DE TOILETTE FOR HER&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1645\" data-caption=\"FDA Advisory No.2024-1645 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;LA BELLA VIVA EAU DE TOILETTE FOR HER&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1645-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1645-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-la-bella-viva-eau-de-toilette-for-her\/\">FDA Advisory No.2024-1645 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;LA BELLA VIVA EAU DE TOILETTE FOR HER&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93761","class":"post-row post-type-post post-93761 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637.png\" class=\"\" alt=\"FDA Advisory No.2024-1637 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;YESHUI SAKURA NIACINAMIDE BODY LOTION&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1637\" data-caption=\"FDA Advisory No.2024-1637 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;YESHUI SAKURA NIACINAMIDE BODY LOTION&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1637-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1637-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-yeshui-sakura-niacinamide-body-lotion\/\">FDA Advisory No.2024-1637 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;YESHUI SAKURA NIACINAMIDE BODY LOTION&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93765","class":"post-row post-type-post post-93765 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634.png\" class=\"\" alt=\"FDA Advisory No.2024-1634 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;BEST BEAUTY&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1634\" data-caption=\"FDA Advisory No.2024-1634 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;BEST BEAUTY&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1634-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1634-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-best-beauty\/\">FDA Advisory No.2024-1634 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;BEST BEAUTY&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93757","class":"post-row post-type-post post-93757 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633.png\" class=\"\" alt=\"FDA Advisory No.2024-1633 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;HEROLISA&#039;S WHITENING BLEACHING BODY CREAM&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1633\" data-caption=\"FDA Advisory No.2024-1633 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;HEROLISA&#039;S WHITENING BLEACHING BODY CREAM&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1633-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1633-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-herolisas-whitening-bleaching-body-cream\/\">FDA Advisory No.2024-1633 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;HEROLISA&#8217;S WHITENING BLEACHING BODY CREAM&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93753","class":"post-row post-type-post post-93753 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636.png\" class=\"\" alt=\"FDA Advisory No.2024-1636 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;EXGYAN CHERRY BLOSSOM BODY LOTION&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1636\" data-caption=\"FDA Advisory No.2024-1636 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;EXGYAN CHERRY BLOSSOM BODY LOTION&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1636-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1636-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-exgyan-cherry-blossom-body-lotion\/\">FDA Advisory No.2024-1636 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;EXGYAN CHERRY BLOSSOM BODY LOTION&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93752","class":"post-row post-type-post post-93752 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632.png\" class=\"\" alt=\"FDA Advisory No.2024-1632 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON GUAVA NIACINAMIDE NATURAL SOAP&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1632\" data-caption=\"FDA Advisory No.2024-1632 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON GUAVA NIACINAMIDE NATURAL SOAP&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1632-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1632-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-magayon-guava-niacinamide-natural-soap\/\">FDA Advisory No.2024-1632 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MAGAYON GUAVA NIACINAMIDE NATURAL SOAP&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93745","class":"post-row post-type-post post-93745 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631.png\" class=\"\" alt=\"FDA Advisory No.2024-1631 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS ENCAPSULATED RETINOL FIRMING GOOD NIGHT MASK&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1631\" data-caption=\"FDA Advisory No.2024-1631 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS ENCAPSULATED RETINOL FIRMING GOOD NIGHT MASK&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1631-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1631-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-magayon-organics-encapsulated-retinol-firming-good-night-mask\/\">FDA Advisory No.2024-1631 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MAGAYON ORGANICS ENCAPSULATED RETINOL FIRMING GOOD NIGHT MASK&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93741","class":"post-row post-type-post post-93741 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635.png\" class=\"\" alt=\"FDA Advisory No.2024-1635 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;YUUKO COLLAGEN ANTI-AGING WHITENING TONING GLOWING CREAM SPF50&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1635\" data-caption=\"FDA Advisory No.2024-1635 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;YUUKO COLLAGEN ANTI-AGING WHITENING TONING GLOWING CREAM SPF50&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1635-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1635-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-yuuko-collagen-anti-aging-whitening-toning-glowing-cream-spf50\/\">FDA Advisory No.2024-1635 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;YUUKO COLLAGEN ANTI-AGING WHITENING TONING GLOWING CREAM SPF50&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93740","class":"post-row post-type-post post-93740 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630.png\" class=\"\" alt=\"FDA Advisory No.2024-1630 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS PH BALANCING TONER NO. 2&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1630\" data-caption=\"FDA Advisory No.2024-1630 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS PH BALANCING TONER NO. 2&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1630-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1630-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-magayon-organics-ph-balancing-toner-no-2\/\">FDA Advisory No.2024-1630 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MAGAYON ORGANICS PH BALANCING TONER NO. 2&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93736","class":"post-row post-type-post post-93736 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629.png\" class=\"\" alt=\"FDA Advisory No.2024-1629 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS REVITALIZING SERUM NO. 3&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1629\" data-caption=\"FDA Advisory No.2024-1629 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS REVITALIZING SERUM NO. 3&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1629-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1629-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-magayon-organics-revitalizing-serum-no-3\/\">FDA Advisory No.2024-1629 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MAGAYON ORGANICS REVITALIZING SERUM NO. 3&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93732","class":"post-row post-type-post post-93732 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628.png\" class=\"\" alt=\"FDA Advisory No.2024-1628 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS SUNSCREEN CREAM GEL BROAD SPECTRUM UV PROTECTION SPF 45&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1628\" data-caption=\"FDA Advisory No.2024-1628 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS SUNSCREEN CREAM GEL BROAD SPECTRUM UV PROTECTION SPF 45&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1628-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1628-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-magayon-organics-sunscreen-cream-gel-broad-spectrum-uv-protection-spf-45\/\">FDA Advisory No.2024-1628 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MAGAYON ORGANICS SUNSCREEN CREAM GEL BROAD SPECTRUM UV PROTECTION SPF 45&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93728","class":"post-row post-type-post post-93728 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627.png\" class=\"\" alt=\"FDA Advisory No.2024-1627 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS SUNSCREEN CLEAR STICK SPF 45&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1627\" data-caption=\"FDA Advisory No.2024-1627 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS SUNSCREEN CLEAR STICK SPF 45&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1627-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1627-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-magayon-organics-sunscreen-clear-stick-spf-45\/\">FDA Advisory No.2024-1627 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MAGAYON ORGANICS SUNSCREEN CLEAR STICK SPF 45&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93724","class":"post-row post-type-post post-93724 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626.png\" class=\"\" alt=\"FDA Advisory No.2024-1626 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS CHARCOAL PURE BLACK DETOXIFYING SOAP&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1626\" data-caption=\"FDA Advisory No.2024-1626 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MAGAYON ORGANICS CHARCOAL PURE BLACK DETOXIFYING SOAP&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1626-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1626-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-magayon-organics-charcoal-pure-black-detoxifying-soap\/\">FDA Advisory No.2024-1626 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MAGAYON ORGANICS CHARCOAL PURE BLACK DETOXIFYING SOAP&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93720","class":"post-row post-type-post post-93720 publish"},"date":" 9 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622.png\" class=\"\" alt=\"FDA Advisory No.2024-1622 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MK&#039;SMETICS MADAM KILAY FRESHSKIN REJUVENATING SET&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1622\" data-caption=\"FDA Advisory No.2024-1622 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;MK&#039;SMETICS MADAM KILAY FRESHSKIN REJUVENATING SET&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1622-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1622-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-mksmetics-madam-kilay-freshskin-rejuvenating-set\/\">FDA Advisory No.2024-1622 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;MK&#8217;SMETICS MADAM KILAY FRESHSKIN REJUVENATING SET&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93664","class":"post-row post-type-post post-93664 publish"},"date":" 3 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1625-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cPhenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte)        10 mg\/2 mg\/500 mg Tablet (Lot No. 21004812, Expiry Date: DEC 2026)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1625-A\" data-caption=\"FDA Advisory No.2024-1625-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cPhenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte)        10 mg\/2 mg\/500 mg Tablet (Lot No. 21004812, Expiry Date: DEC 2026)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1625-a-babala-sa-publiko-tungkol-sa-paggamit-ng-beripikadong-pekeng-gamot-na-phenylephrine-hydrochloride-chlorphenamine-maleate-paracetamol-neozep-forte\/\">FDA Advisory No.2024-1625-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cPhenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte)        10 mg\/2 mg\/500 mg Tablet (Lot No. 21004812, Expiry Date: DEC 2026)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93660","class":"post-row post-type-post post-93660 publish"},"date":" 3 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625.png\" class=\"\" alt=\"FDA Advisory No.2024-1625 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cPhenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte)          10 mg\/2 mg\/500 mg Tablet (Lot No. 21004812, Expiry Date: DEC 2026)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1625\" data-caption=\"FDA Advisory No.2024-1625 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cPhenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte)          10 mg\/2 mg\/500 mg Tablet (Lot No. 21004812, Expiry Date: DEC 2026)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2024-1625-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1625-public-health-warning-against-the-purchase-and-use-of-the-counterfeit-drug-product-phenylephrine-hydrochloride-chlorphenamine-maleate-paracetamol-neozep\/\">FDA Advisory No.2024-1625 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cPhenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte)          10 mg\/2 mg\/500 mg Tablet (Lot No. 21004812, Expiry Date: DEC 2026)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93656","class":"post-row post-type-post post-93656 publish"},"date":" 3 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1624-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cPhenylephrine HCl + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte) 10 mg\/2 mg\/500 mg Tablet (Lot No. 23068770, Expiry Date: SEP 2026)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2021-1624-A\" data-caption=\"FDA Advisory No.2024-1624-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cPhenylephrine HCl + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte) 10 mg\/2 mg\/500 mg Tablet (Lot No. 23068770, Expiry Date: SEP 2026)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1624-a-babala-sa-publiko-tungkol-sa-paggamit-ng-beripikadong-pekeng-gamot-na-phenylephrine-hcl-chlorphenamine-maleate-paracetamol-neozep-forte-10-mg-2-mg-5\/\">FDA Advisory No.2024-1624-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cPhenylephrine HCl + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte) 10 mg\/2 mg\/500 mg Tablet (Lot No. 23068770, Expiry Date: SEP 2026)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93652","class":"post-row post-type-post post-93652 publish"},"date":" 3 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624.png\" class=\"\" alt=\"FDA Advisory No.2024-1624 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cPhenylephrine HCl + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte) 10 mg\/2 mg\/500 mg Tablet (Lot No. 23068770, Expiry Date: SEP 2026)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2021-1624\" data-caption=\"FDA Advisory No.2024-1624 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cPhenylephrine HCl + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte) 10 mg\/2 mg\/500 mg Tablet (Lot No. 23068770, Expiry Date: SEP 2026)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/FDA-Advisory-No.2021-1624-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1624-public-health-warning-against-the-purchase-and-use-of-the-counterfeit-drug-product-phenylephrine-hcl-chlorphenamine-maleate-paracetamol-neozep-forte-1\/\">FDA Advisory No.2024-1624 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cPhenylephrine HCl + Chlorphenamine Maleate + Paracetamol (Neozep\u00ae Forte) 10 mg\/2 mg\/500 mg Tablet (Lot No. 23068770, Expiry Date: SEP 2026)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93634","class":"post-row post-type-post post-93634 publish"},"date":" 2 December 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623.png\" class=\"\" alt=\"FDA Advisory No.2024-1623 || Frequently-Asked Questions (FAQs) on the Submission of Sales Promotion Permit Applications\" loading=\"lazy\" title=\"DA Advisory No.2024-1623\" data-caption=\"FDA Advisory No.2024-1623 || Frequently-Asked Questions (FAQs) on the Submission of Sales Promotion Permit Applications\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/12\/DA-Advisory-No.2024-1623-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1623-frequently-asked-questions-faqs-on-the-submission-of-sales-promotion-permit-applications\/\">FDA Advisory No.2024-1623 || Frequently-Asked Questions (FAQs) on the Submission of Sales Promotion Permit Applications<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93585","class":"post-row post-type-post post-93585 publish"},"date":" 29 November 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2.png\" class=\"\" alt=\"FDA Advisory No.2024-1621 || VOLUNTARY PRODUCT RECALL OF MINIVERSE - MAKE IT MINI\/MINI TOYS\" loading=\"lazy\" title=\"_New - FDA Advisory\" data-caption=\"FDA Advisory No.2024-1621 || VOLUNTARY PRODUCT RECALL OF MINIVERSE - MAKE IT MINI\/MINI TOYS\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/New-FDA-Advisory-2-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1621-voluntary-product-recall-of-miniverse-make-it-mini-mini-toys\/\">FDA Advisory No.2024-1621 || VOLUNTARY PRODUCT RECALL OF MINIVERSE &#8211; MAKE IT MINI\/MINI TOYS<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93567","class":"post-row post-type-post post-93567 publish"},"date":" 29 November 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1089-A || Conclusion of the Pilot Implementation of the Food and Drug Administration (FDA) eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN) within the National Capital Region (NCR)\" loading=\"lazy\" title=\"FDA Advisory No.2024-1089-A\" data-caption=\"FDA Advisory No.2024-1089-A || Conclusion of the Pilot Implementation of the Food and Drug Administration (FDA) eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN) within the National Capital Region (NCR)\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1089-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1089-a-conclusion-of-the-pilot-implementation-of-the-food-and-drug-administration-fda-eservices-portal-system-for-the-initial-application-of-a-certificate-of-medical-device-n\/\">FDA Advisory No.2024-1089-A || Conclusion of the Pilot Implementation of the Food and Drug Administration (FDA) eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN) within the National Capital Region (NCR)<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/device-advisories\/\" rel=\"category tag\">Device Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93518","class":"post-row post-type-post post-93518 publish"},"date":" 26 November 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620.png\" class=\"\" alt=\"FDA Advisory No.2024-1620 || Voluntary Product Recall of Specific Batch of Co-Amoxiclav 457 mg\/5 mL Powder for Suspension 35 mL [Augmentin] with Batch No. ET4E, Expiry Date: 10\/2025\" loading=\"lazy\" title=\"FDA Advisory No.2024-1620\" data-caption=\"FDA Advisory No.2024-1620 || Voluntary Product Recall of Specific Batch of Co-Amoxiclav 457 mg\/5 mL Powder for Suspension 35 mL [Augmentin] with Batch No. ET4E, Expiry Date: 10\/2025\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1620-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1620-voluntary-product-recall-of-specific-batch-of-co-amoxiclav-457-mg-5-ml-powder-for-suspension-35-ml-augmentin-with-batch-no-et4e-expiry-date-10-2025\/\">FDA Advisory No.2024-1620 || Voluntary Product Recall of Specific Batch of Co-Amoxiclav 457 mg\/5 mL Powder for Suspension 35 mL [Augmentin] with Batch No. ET4E, Expiry Date: 10\/2025<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93486","class":"post-row post-type-post post-93486 publish"},"date":" 25 November 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619.png\" class=\"\" alt=\"FDA Advisory No.2024-1619 || Public Health Warning on Falsified\/Counterfeit Hepatitis B Vaccine (Recombinant DNA) (Genvac-B) notified by the Genuine Product Manufacturer to the World Health Organization (WHO)\" loading=\"lazy\" title=\"1619\" data-caption=\"FDA Advisory No.2024-1619 || Public Health Warning on Falsified\/Counterfeit Hepatitis B Vaccine (Recombinant DNA) (Genvac-B) notified by the Genuine Product Manufacturer to the World Health Organization (WHO)\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1619-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1619-public-health-warning-on-falsified-counterfeit-hepatitis-b-vaccine-recombinant-dna-genvac-b-notified-by-the-genuine-product-manufacturer-to-the-world-health-organizati\/\">FDA Advisory No.2024-1619 || Public Health Warning on Falsified\/Counterfeit Hepatitis B Vaccine (Recombinant DNA) (Genvac-B) notified by the Genuine Product Manufacturer to the World Health Organization (WHO)<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93481","class":"post-row post-type-post post-93481 publish"},"date":" 25 November 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618.png\" class=\"\" alt=\"FDA Advisory No.2024-1618 || Endorsement of Updates on the List of VAT-Exempt Health Products\" loading=\"lazy\" title=\"1618\" data-caption=\"FDA Advisory No.2024-1618 || Endorsement of Updates on the List of VAT-Exempt Health Products\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/1618-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1618-endorsement-of-updates-on-the-list-of-vat-exempt-health-products\/\">FDA Advisory No.2024-1618 || Endorsement of Updates on the List of VAT-Exempt Health Products<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/general-advisories\/\" rel=\"category tag\">General Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93470","class":"post-row post-type-post post-93470 publish"},"date":" 21 November 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617.png\" class=\"\" alt=\"FDA Advisory No.2024-1617 || Invitation to FDA POLICY FORUM: Regulations Governing the FDA Fees Structures, Licensing System and Registration of Pharmaceutical Products\" loading=\"lazy\" title=\"FDA Advisory No.2024-1617\" data-caption=\"FDA Advisory No.2024-1617 || Invitation to FDA POLICY FORUM: Regulations Governing the FDA Fees Structures, Licensing System and Registration of Pharmaceutical Products\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1617-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1617-invitation-to-fda-policy-forum-regulations-governing-the-fda-fees-structures-licensing-system-and-registration-of-pharmaceutical-products\/\">FDA Advisory No.2024-1617 || Invitation to FDA POLICY FORUM: Regulations Governing the FDA Fees Structures, Licensing System and Registration of Pharmaceutical Products<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/general-advisories\/\" rel=\"category tag\">General Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93418","class":"post-row post-type-post post-93418 publish"},"date":" 18 November 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616.png\" class=\"\" alt=\"FDA Advisory No.2024-1616 || REITERATION OF SUBMISSION OF BATCH NOTIFICATION REPRESENTATIVE SAMPLE\/S AND REQUIRED DOCUMENT\/S (POST SUBMISSION)\" loading=\"lazy\" title=\"FDA Advisory No.2024-1616\" data-caption=\"FDA Advisory No.2024-1616 || REITERATION OF SUBMISSION OF BATCH NOTIFICATION REPRESENTATIVE SAMPLE\/S AND REQUIRED DOCUMENT\/S (POST SUBMISSION)\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1616-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1616-reiteration-of-submission-of-batch-notification-representative-sample-s-and-required-document-s-post-submission\/\">FDA Advisory No.2024-1616 || REITERATION OF SUBMISSION OF BATCH NOTIFICATION REPRESENTATIVE SAMPLE\/S AND REQUIRED DOCUMENT\/S (POST SUBMISSION)<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/general-advisories\/\" rel=\"category tag\">General Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93414","class":"post-row post-type-post post-93414 publish"},"date":" 18 November 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575.png\" class=\"\" alt=\"FDA Advisory No.2024-1575 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product \u201cECOFIT Natural Slimming Capsule 500mg Dietary Supplement&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1575\" data-caption=\"FDA Advisory No.2024-1575 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product \u201cECOFIT Natural Slimming Capsule 500mg Dietary Supplement&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1575-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1575-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-product-ecofit-natural-slimming-capsule-500mg-dietary-supplement\/\">FDA Advisory No.2024-1575 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product \u201cECOFIT Natural Slimming Capsule 500mg Dietary Supplement&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-93400","class":"post-row post-type-post post-93400 publish"},"date":" 15 November 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488.png\" class=\"\" alt=\"FDA Advisory No.2024-1488 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1488\" data-caption=\"FDA Advisory No.2024-1488 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/11\/FDA-Advisory-No.2024-1488-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1488-public-health-warning-against-the-purchase-and-use-of-the-unnotified-medical-device-products\/\">FDA Advisory No.2024-1488 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/device-advisories\/\" rel=\"category tag\">Device Advisories<\/a>","categories_hfilter":""}]}
